苗药“仰纠”——鬼针草治疗静脉血栓研究
Study on the Treatment of Venous Thrombosis by the Miao Medicinal Herb“Yangjiu”—Bidens Pilosa L.
DOI: 10.12677/TCM.2023.1212527, PDF,    科研立项经费支持
作者: 陈 帅, 陈云志, 黄垂巧, 资石祥:贵州中医药大学基础医学院,贵州 贵阳;潘科廷*:贵州中医药大学第二附属医院急诊科,贵州 贵阳
关键词: 静脉血栓鬼针草苗药作用机制Venous Thrombosis Bidens Pilosa L. Miao Medicinal Herb Mechanisms of Action
摘要: 静脉血栓是一种常见的血管疾病,其治疗具有重要的临床意义。鬼针草作为一种传统苗药,对心血管具有良好的保护作用,在传统医学中被广泛应用于治疗心血管疾病,在治疗静脉血栓方面具有潜在的研究和应用价值。本文通过深入研究鬼针草的药理作用,对鬼针草治疗静脉血栓的潜在机制和优势进行了分析,并展望了鬼针草在静脉血栓治疗领域的前景和潜在价值,有望为鬼针草应用于静脉血栓的治疗提供新的思路和方法。
Abstract: Venous thrombosis represents a prevalent vascular disorder, the management of which holds sub-stantial clinical relevance. Bidens Pilosa L., a traditional Miao medicinal herb renowned for its car-diovascular protective properties, is extensively utilized in indigenous medical practices to address a myriad of cardiovascular ailments. This herb holds considerable promise for research and practi-cal applications pertaining to venous thromboembolism treatment. The current study delves into the pharmacological intricacies of Bidens Pilosa L. to elucidate its potential mechanisms and ad-vantages in treating venous thrombosis. Furthermore, this manuscript envisages the future scope and inherent value of Bidens Pilosa L. within the realm of venous thrombosis management, aiming to unveil novel insights and methodologies for its therapeutic deployment against venous throm-bosis.
文章引用:陈帅, 陈云志, 黄垂巧, 资石祥, 潘科廷. 苗药“仰纠”——鬼针草治疗静脉血栓研究[J]. 中医学, 2023, 12(12): 3548-3552. https://doi.org/10.12677/TCM.2023.1212527

参考文献

[1] Lutsey, P.L. and Zakai, N.A. (2023) Epidemiology and Prevention of Venous Thromboembolism. Nature Reviews Car-diology, 20, 248-262. [Google Scholar] [CrossRef] [PubMed]
[2] Khan, F., Tritschler, T., Kahn, S.R. and Rodger, M.A. (2021) Venous Thromboembolism. The Lancet, 398, 64-77. [Google Scholar] [CrossRef
[3] Jin, M.C., Sussman, E.S., Feng, A.Y., Han, S.S., Skirboll, S.L., Berube, C. and Ratliff, J.K. (2021) Hemorrhage Risk of Direct Oral Anticoagulants in Real-World Venous Throm-boembolism Patients. Thrombosis Research, 204, 126-133. [Google Scholar] [CrossRef] [PubMed]
[4] Han, R., Tang, F., Lu, M., et al. (2017) Astragalus Polysac-charide Ameliorates H2O2-Induced Human Umbilical Vein Endothelial Cell Injury. Molecular Medicine Reports, 15, 4027-4034. [Google Scholar] [CrossRef] [PubMed]
[5] Colling, M.E., Tourdot, B.E. and Kanthi, Y. (2021) In-flammation, Infection and Venous Thromboembolism. Circulation Research, 128, 2017-2036. [Google Scholar] [CrossRef
[6] Jin, M.C., Sussman, E.S., Feng, A.Y., et al. (2021) Hemorrhage Risk of Direct Oral Anticoagulants in Real-World Venous Thromboembolism Patients. Thrombosis Re-search, 204, 126-133. [Google Scholar] [CrossRef] [PubMed]
[7] 周芝兰, 孙可一, 季笑云, 沈灵, 曾琳琳, 周霞. 活血化瘀类中药及复方抗血栓的作用机制研究进展[J]. 中药与临床, 2022, 13(3): 108-112.
[8] 贾敏如, 李星炜. 中国民族药志要[M]. 北京: 中国医药科技出版社, 2005: 93-95.
[9] 文明昌. 黔南苗医药[M]. 北京: 中国文化出版社, 2004: 188.
[10] 王玲, 崔东安, 周绪正, 刘宇. 鬼针草的化学成分与药理作用[J]. 现代药物与临床, 2010, 24(3): 147-150.
[11] 张敬杰, 赵能武, 潘炉台. 苗医治疗疾病常用的菊科植物药(一) [J]. 中国民族医药杂志, 2010, 16(2): 25-26.
[12] 唐东昕, 夏景富. 苗医临床学[M]. 北京: 中国中医药出版社, 2023: 16-26.
[13] 王碧晴, 赵俊男, 张颖, 郭曼萍, 徐凤芹. 鬼针草的药理作用研究进展[J]. 中医药导报, 2019, 25(18): 100-107.
[14] 李庆东. 鬼针草抗实验性高血脂及血栓形成的作用[J]. 中西医结合杂志, 1989(1): 33.
[15] 赵建伟, 张文贤, 王斌, 苏奇, 严其凯. 中医防治深静脉血栓形成的研究进展[J]. 中医临床研究, 2021, 13(10): 142-145.
[16] 沈艺玮, 林丽清, 林新华, 姚宏. 鬼针草的化学成分及药理活性研究进展[J]. 福建医科大学学报, 2015, 49(1): 58-61.
[17] 史大卓, 徐浩, 殷惠军, 张京春, 陈可冀. “瘀”、“毒”从化——心脑血管血栓性疾病病因病机[J]. 中西医结合学报, 2008, 6(11): 1105-1108.
[18] 刘娜. 鬼针草药理作用研究进展[J]. 海峡药学, 2019, 31(12): 64-67.
[19] 金星漂, 王钰乐, 贺爽, 张砚, 朱彦. 炎症免疫调节作为活血化瘀中药防治深静脉血栓新策略的探讨[J]. 中草药, 2019, 50(11): 2718-2725.
[20] 潘海敏, 方慧华, 严士海. 鬼针草总黄酮对体外血小板聚集的影响[J]. 医药导报, 2011, 30(10): 1273-1274.
[21] 林梅英, 陈飞虎, 葛金芳, 唐杰, 倪文琳. 鬼针草总黄酮对急性炎症的保护作用及可能机制研究[J]. 中国临床药理学与治疗学, 2013, 18(6): 614-620.
[22] 黄川锋, 马瑜红, 周新, 李玲, 郝海鸥. 鬼针草提取物对实验性高脂血症大鼠血脂和NO及NOS的影响[J]. 中国现代药物应用, 2009, 3(17): 14-16.
[23] Henke, P. (2022) Endothelial Cell-Mediated Venous Thrombosis. Blood, 140, 1459-1460. [Google Scholar] [CrossRef] [PubMed]